Abstract
Depression is a severe and life-threatening psychiatric illness whose pathogenesis is still essentially unknown. Proteomic analysis of synaptic terminals (synaptoproteomics) in animal models of depression is a powerful approach to gain insight into the molecular mechanisms underlying vulnerability to mood disorders and the long-term action of drug treatments. Here, we employed two different animal models of depression, the Learned Helplessness rats (a classical behavioral model of depression) and a new model of depression with gene—environment interaction (Flinders Sensitive Line rats subjected to early life stress). Both animal models were treated with the antidepressant escitalopram. Analysis of their synaptoproteomic profile revealed a number of protein spots differently regulated by basic vulnerability and/or early life stress. Using this approach, we obtained information regarding biomarkers that may represent predictors of pathology or response/resistance to drug treatment, as well as potential targets for novel pharmacological and therapeutic strategies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- 2D:
-
Two-dimensional
- 5-HT1A :
-
Serotonin 1A receptor
- BCA:
-
Bicinchoninic Acid
- CHAPS:
-
(3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate)
- DA:
-
Dopamine
- DAVID:
-
Database for Annotation, Visualization and Integrated Discovery
- ESC:
-
Escitalopram
- FRL:
-
Flinders sensitive line
- FSL:
-
Flinders resistant line
- G × E:
-
Gene—environment interaction
- GO:
-
Gene Ontology
- HC:
-
Hippocampus
- HPA:
-
Hypothalamic—pituitary—adrenal
- IBS:
-
Inflammatory bowel syndrome
- IEF:
-
Isoelectric focusing
- IPA:
-
Ingenuity pathways analysis
- IPG:
-
Immobilized pH gradient
- LH:
-
Learned helplessness
- mRNA:
-
Messenger RNA
- MS:
-
Maternal separation
- nLH:
-
Non-learned helplessness
- NMDA:
-
N-methyl-D-aspartate
- P/FC:
-
Prefrontal/frontal cortex
- pI:
-
Isoelectric point
- PND:
-
Post natal day
- REM:
-
Random eyes movement
- SDS:
-
Sodium dodecyl sulfate
- SDS-PAGE:
-
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
- Tris:
-
Tris(hydroxymethyl)aminomethane
- Veh:
-
Vehicle
References
Al-Shahrour F, Diaz-Uriarte R, Dopazo J (2004) FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 20:578–580
Al-Shahrour F, Minguez P, Vaquerizas JM, Conde L, Dopazo J (2005) BABELOMICS: a suit of web tools for functional annotation and analysis of groups of genes in high-throughput experiments. Nucleic Acids Res 33:W460–W464
Anderson L, Seilhamer J (1997) A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18:533–537
Barbiero VS, Giambelli R, Musazzi L, Tiraboschi E, Tardito D, Perez J, Drago F, Racagni G, Popoli M (2007) Chronic antidepressants induce redistribution and differential activation of alphaCaM Kinase II between presynaptic compartments. Neuropsychopharmacology advance online publication, 14 March 2007; doi:10.1038/sj.npp.1301378
Bonanno G, Giambelli R, Raiteri L, Tiraboschi E, Zappettini S, Musazzi L, Raiteri M, Racagni G, Popoli M (2005) Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci 25:3270–3279
Boyd-Kimball D, Castegna A, Sultana R, Poon HF, Petroze R, Lynn BC, Klein JB, Butterfield DA (2005) Proteomic identification of proteins oxidized by Abeta(1–42) in synaptosomes: implications for Alzheimer's disease. Brain Res 1044:206–215
Caldji C, Francis D, Sharma S, Plotsky PM, Meaney MJ (2000) The effects of early rearing environment on the devepopment of GABAA and central benzodiazepine receptor levels and novelty-induced fearfulness in the rat. Neuropsychopharmacology 22:219–229
Caspi A, Moffitt TE (2006) Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 7:583–590
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389
Carboni L, Piubelli C, Righetti PG, Jansson B, Domenici E (2002) Proteomic analysis of rat brain tissue: comparison of protocols for two-dimensional gel electrophoresis analysis based on different solubilizing agents. Electrophoresis 23:4132–4141
Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA (2003) DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4:P3
Dunkley PR, Jarvie PE, Heath JW, Kidd GJ, Rostas JA (1986) A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res 372:115–129
El Khoury A, Gruber SHM, Mϕrk A, Mathé AA (2006) Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression. Prog Neuropsychopharmacol Biol Psychiatr 30:535–540
Fountoulakis M (2004) Application of proteomiics technologies in the investigation of the brain. Mass Spectrom Rev 23:231–258
Heim C, Nemeroff CB (2001) The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatr 49:1023–1039
Henn FA, Edwards E, Anderson D, Vollmayr B (2002) Psychotherapy and antidepressant treatment of depression: evidence for similar neurobiological mechanism. World Psychiatr 1:115–117
Hitzemann R (2000) Animal models of psychiatric disorders and their relevance to alcoholism. Alcohol Res Healt 3:149–158
Janowsky DS, Risch SC, Parker D, Huey L, Judd L (1980) Increased vulnerability to cholinergic stimulation in affect disorder patients. Psychopharmacol Bull 16:29–31
Janowsky DS, Overstreet DH, Nurnberger JI Jr (1994) Is cholinergic sensitivity a genetic marker for the affective disorders? Am J Med Genet 54:335–344
Keller MB, Boland RJ (1998) Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatr 44:348–360
Kramer R, Cohen D (2004) Functional genomics to new drug targets. Nat Rev Drug Discov 3:965–72
Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, Plotsky PM (2000) Long-term behavioural and neuroendocrine adaptations to adverse early experience. Prog Brain Res 122:81–103
Lesch KP (2004) Gene-environment interaction and the genetics of depression. J Psychiatr Neurosci 29:174–84
Li KW, Hornshaw MP, Van Der Schors RC, Watson R, Tate S, Casetta B, Jimenez CR, Gouwenberg Y, Gundelfinger ED, Smalla KH, Smit AB (2004) Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology. J Biol Chem 279:987–1002
Liberatori S, Canas B, Tani C, Bini L, Buonocore G, Godovac-Zimmermann J, Mishra OP, Delivoria-Papadopoulos M, Bracci R, Pallini V (2004) Proteomic approach to the identification of voltage-dependent anion channel protein isoforms in guinea pig brain synaptosomes. Proteomics 4:1335–1340
Matthews K, Christmas D, Swan J, Sorrel E (2005) Animal models of depression: navigating through the clinical fog. Neurosci Biobehav Rev 29:503–513
Mello CF, Sultana R, Piroddi M, Cai J, Pierce WM, Klein JB, Butterfield DA (2007) Acrolein induces selective protein carbonylation in synaptosomes. Neuroscience 147:674–679
Musazzi L, Ryan B, Barbiero VS, Mallei A, Giambelli R, Tardito D, Gruber SHM, El Khoury A, Andersson W, Anwyl R, Racagni G, Mathé AA, Rowan MJ, Popoli M Early-life stress enhances NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. Submitted Proc Natl Acad Sci USA 2007
Overmier JB, Seligman ME (1967) Effects of inescapable shock upon subsequent escape and avoidance responding. J Comp Physiol Psychol 63:28–33
Overstreet DH, Russell RW (1982) Selective breeding for diisopropyl fuorophosphate-sensitivity: behavioural effects of cholinergic agonists and antagonists. Psychopharmacology (Berl.) 78:150–155
Overstreet DH, Friedman E, Mathé AA, Yadid G (2005) The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev 29:739–759
Paulson L, Martin P, Persson A, Nilsson CL, Ljung E, Westman-Brinkmalm A, Eriksson PS, Blennow K, Davidsson P (2003) Comparative genome- and proteome analysis of cerebral cortex from MK-801-treated rats. J Neurosci Res 71:526–533
Plotsky PM, Meaney MJ (1993) Early, postnatal experience alters hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF content and stress-induced release in adult rats. Brain Res Mol Brain Res 18:195–200
Pucilowski O, Overstreet DH, Rezvani AH, Janowsky DS (1993) Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol Behav 54:1215–1220
Raiteri L, Raiteri M (2000) Synaptosomes still viable after 25 years of superfusion. Neurochem Res 25:1265–1274
Rohlff C, Hollis K (2003) Modern proteomic strategies in the study of complex neuropsychiatric disorders. Biol Psychiatr 53:847–853
Russel RW, Overstreet DH (1987) Mechanisms underlying sensitivity to organophosphororus anticholinesterase compounds. Prog Neurobiol 28:97–129
Stasyk T, Huber LA (2004) Zooming in: fractionation strategies in proteomics. Proteomics 4:3704–3716
Satoh K, Takeuchi M, Oda Y, Deguchi-Tawarada M, Sakamoto Y, Matsubara K, Nagasu T, Takai Y (2002) Identification of activity-regulated proteins in the postsynaptic density fraction. Genes Cells 7:187–197
Urani A, Chourbaji S, Gass P (2005) Mutant mouse models of depression: candidate genes and current mouse lines. Neurosci Biobehav Rev 29:805–828
Vazquez DM, Lopez JF, Van Hoers H, Watson SJ, Levine S (2000) Maternal deprivation regulates serotonin 1A and 2A receptors in the infant rat. Brain Res 855:76–82
Vercauteren FG, Bergeron JJ, Vandesande F, Arckens L, Quirion R (2004) Proteomic approaches in brain research and neuropharmacology. Eur J Pharmacol 500:385–398
Vollmayr B, Henn FA (2001) Learned helplessness in the rat: improvements in validity and reliability. Brain Res Protoc 8:1–7
Vollmayr B, Henn FA (2003) Stress models of depression. Clin Neurosci Res 3:245–251
Vollmayr B, Simonis C, Weber S, Gass P, Henn FA (2003) Reduced cell proliferation in the dentate gyrus is not correlated with the development of learned helplessness. Biol Psychiatry 54:1035–1040
Wasinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR, Duncan MW, Harris R, Williams KL, Humphery-Smith I (1995) Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16:1090–1094
Willner P (1990) Animal models of depression: an overview. Pharmacol Ther 45:425–455
Willner P (1995) Animal models of depression: validity and applications. Adv Biochem Psychopharmacol 49:19–41
Wishart TM, Paterson JM, Short DM, Meredith S, Robertson KA, Sutherland C, Cousin MA, Dutia MB, Gillingwater TH (2007) Differential proteomic analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wld) gene. Mol Cell Proteomics 8:1318–1330
Witzmann FA, Arnold RJ, Bai F, Hrncirova P, Kimpel MW, Mechref YS, McBride WJ, Novotny MV, Pedrick NM, Ringham HN, Simon JR (2005) A proteomic survey of rat cerebral cortical synaptosomes. Proteomics 5:2177–2201
Yadid G, Nakash R, Deri I, Tamar G, Kinor N, Gispan I, Zangen A (2000) Elucidation of the neurobiology of depression: insights from a novel genetic animal model. Prog Neurobiol 62:353–378
Acknowledgments
This work was funded by a European Union (6th Framework Program) grant for project GENDEP (contract no. LSHB-CT-2003-503428) and by the Swedish Medical Research Council grant 10414 (to AAM).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Mallei, A. et al. (2008). Synaptoproteomics of Existing and new Animal Models of Depression. In: Turck, C. (eds) Biomarkers for Psychiatric Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-79251-4_8
Download citation
DOI: https://doi.org/10.1007/978-0-387-79251-4_8
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-79250-7
Online ISBN: 978-0-387-79251-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)